Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tandem Diabetes Care (TNDM) Non Operating Income (2016 - 2025)

Tandem Diabetes Care's Non Operating Income history spans 13 years, with the latest figure at -$3.6 million for Q4 2025.

  • For Q4 2025, Non Operating Income fell 704.01% year-over-year to -$3.6 million; the TTM value through Dec 2025 reached -$13.0 million, down 279.34%, while the annual FY2025 figure was -$13.0 million, 279.34% down from the prior year.
  • Non Operating Income reached -$3.6 million in Q4 2025 per TNDM's latest filing, down from -$2.3 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $4.2 million in Q1 2023 to a low of -$5.9 million in Q2 2025.
  • Average Non Operating Income over 5 years is $23100.0, with a median of -$283500.0 recorded in 2022.
  • Peak YoY movement for Non Operating Income: skyrocketed 687.76% in 2023, then tumbled 704.01% in 2025.
  • A 5-year view of Non Operating Income shows it stood at -$1.6 million in 2021, then skyrocketed by 204.46% to $1.7 million in 2022, then skyrocketed by 125.36% to $3.8 million in 2023, then tumbled by 84.05% to $598000.0 in 2024, then plummeted by 704.01% to -$3.6 million in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Non Operating Income are -$3.6 million (Q4 2025), -$2.3 million (Q3 2025), and -$5.9 million (Q2 2025).